All the latest worldwide HIV and AIDS news, including treatment, prevention, and hepatitis and TB co-infections. News from our own team of writers plus articles we have selected from other sources.

aidsmap hiv & aids news

RSS

← First12345...859Next →

hiv & aids news selected from other sources

  • Finance and funding
    South Africa: Cutting U.S. funding will harm people with HIV most
    Health GAP | 8 hours ago

    Arguably the biggest challenge facing South Africa’s HIV response today is how to support many more people living with HIV to start and, importantly, stay on treatment. Doing this in the context of a dysfunctional healthcare system will not be easy, but cannot be shied away from. Yet instead of receiving commitment to do what it will take to make this happen, South Africa is facing the threat of dramatic cuts in U.S. government funding that risk derailing future progress, gambling with people’s health and lives.

  • People and personal stories
    Ageing with HIV: Testimonials of Stigma and Discrimination in Healthcare Settings
    EATG | 8 hours ago

    So frequent were the stories that emerged of poor understanding and stigmatising attitudes to people with HIV from professionals working in medical services outside their HIV clinic, and so strong the fears of how people might be treated in these settings, that many participants with HIV reported a strong reluctance to access services which they needed for their ongoing good health, from surgery to dentistry and maternity services. These stories come from all parts of Europe.

  • Harm reduction
    New “Generic” Naloxone: Expect More Big-Pharma Sleight of Hand
    Filter | 8 hours ago

    It’s been less than two weeks since the US Department of Justice joined a string of lawsuits against Indivior—the maker of the drug Suboxone, which is used to treat opioid use disorder— alleging the company engaged in a fraudulent patent-hopping scheme designed to prevent cheaper generic versions of the drug (a combination of buprenorphine and naloxone) from hitting market. Now the Food and Drug Administration has set the stage for yet another legal battle over lifesaving medication—and if history is a guide, profits are likely to be prioritized over people.

  • Pharmaceutical industry
    US: The Justice Department Is Looking Into Gilead’s PrEP Profits
    Out | 8 hours ago

    The Justice Department will investigate whether drug manufacturer Gilead violated the terms of the federal government’s patent on Truvada as pre-exposure prophylaxis, according to the Washington Post.

  • Access to medicines and treatment
    HIV Medical Providers Strongly Oppose Proposed Changes To Medicare Drug Plan’s “Protected Classes”
    Poz | 10 hours ago

    The proposed rule would allow plans to exclude certain drugs in those protected classes, including antiretrovirals.

  • Migrants, refugees and displaced people
    Transgender Immigration detainee died of AIDS complications, autopsy shows
    CBS News | 24 April 2019

    The official autopsy for Honduran migrant Roxsana Hernandez found she had "untreated HIV." Advocates say she was detained after requesting asylum. “I think this person was denied the minimum standard required by U.S. law for prisoners and detainees,” Dr. Chris Beyrer, a public health professor at Johns Hopkins University, told NBC News after reviewing the official autopsy report.

  • Delivery of care
    'Stigma does not go away': Mumbai’s dedicated LGBT health clinic
    The Guardian | 24 April 2019

    After reports of transgender people being refused treatment, a new centre offers specialised services – and respite from discrimination

  • Clinical trials
    Why Do Study Participants Misreport Their HIV Status?
    The Body Pro | 24 April 2019

    Why do some study volunteers misreport their HIV status to researchers? Maybe they misunderstood the conditions for incentive payments or the question itself, speculated the authors of a recent study on the subject. Or maybe the questions were not phrased in a way that is easy for laypersons to understand, countered David Malebranche, M.D., M.P.H., of Morehouse School of Medicine.

  • PrEP science
    PrEP May Offer Psychological Benefits to Gay, Bisexual Men at Risk for HIV
    American Journal of Managed Care | 24 April 2019

    A new study has identified lower rates of sexual anxiety among gay and bisexual men taking pre-exposure prophylaxis (PrEP).

  • Retention and linkage to care
    Confidentiality breaches, stigma and a lack of time are stopping men in Côte d’Ivoire from getting tested and treated for HIV
    AVERT | 24 April 2019

    Interviews with men in Côte d’Ivoire reveal radical differences in the perceptions of those who do and don’t access care. Research, published in PLOS ONE, found many of the worries of men out of care are not reflected in the experiences of those with regular contact with services. Men’s perceptions were linked with their level of engagement with HIV care, with men who have regular contact with HIV testing and treatment services displaying more positive attitudes than those with little or no contact with such services. The paper can be seen at https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0211385

← First12345...14Next →

Conference news

News from the Conference on Retroviruses and Opportunistic Infections (CROI 2019).

aidsmapLIVE

Watch our AIDS 2018 aidsmapLIVE panel discussion on YouTube.

HIV update

Sign up for HIV update, our fortnightly news bulletin for people living with HIV in the UK.

New EUROBulletin

Read the December edition of the Sexual Health & HIV Policy EUROBulletin.

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.